Literature DB >> 24881644

Does stress induce bowel dysfunction?

Yu-Ming Chang1, Mohamad El-Zaatari, John Y Kao.   

Abstract

Psychological stress is known to induce somatic symptoms. Classically, many gut physiological responses to stress are mediated by the hypothalamus-pituitary-adrenal axis. There is, however, a growing body of evidence of stress-induced corticotrophin-releasing factor (CRF) release causing bowel dysfunction through multiple pathways, either through the HPA axis, the autonomic nervous systems, or directly on the bowel itself. In addition, recent findings of CRF influencing the composition of gut microbiota lend support for the use of probiotics, antibiotics, and other microbiota-altering agents as potential therapeutic measures in stress-induced bowel dysfunction.

Entities:  

Keywords:  NLRP6; bowel dysfunction; irritable bowel syndrome; microbiota; stress

Mesh:

Substances:

Year:  2014        PMID: 24881644      PMCID: PMC4249634          DOI: 10.1586/17474124.2014.911659

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  29 in total

1.  Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness.

Authors:  Simon R Knowles; Elizabeth A Nelson; Enzo A Palombo
Journal:  Biol Psychol       Date:  2007-10-02       Impact factor: 3.251

Review 2.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

3.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

4.  Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction.

Authors:  A Ait-Belgnaoui; W Han; F Lamine; H Eutamene; J Fioramonti; L Bueno; V Theodorou
Journal:  Gut       Date:  2006-02-28       Impact factor: 23.059

5.  Immune activation in patients with irritable bowel syndrome.

Authors:  Tobias Liebregts; Birgit Adam; Christoph Bredack; Alexander Röth; Susanne Heinzel; Sue Lester; Sarah Downie-Doyle; Eric Smith; Paul Drew; Nicholas J Talley; Gerald Holtmann
Journal:  Gastroenterology       Date:  2007-01-26       Impact factor: 22.682

6.  Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Buyi Zhang; G Nicholas Verne
Journal:  Pain       Date:  2009-11       Impact factor: 6.961

Review 7.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Authors:  P Moayyedi; A C Ford; N J Talley; F Cremonini; A E Foxx-Orenstein; L J Brandt; E M M Quigley
Journal:  Gut       Date:  2008-12-17       Impact factor: 23.059

8.  Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD.

Authors:  Jessica Gill; Meena Vythilingam; Gayle G Page
Journal:  J Trauma Stress       Date:  2008-12

9.  Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats.

Authors:  Hélène Eutamene; Florence Lamine; Chantal Chabo; Vassilia Theodorou; Florence Rochat; Gabriela E Bergonzelli; Irène Corthésy-Theulaz; Jean Fioramonti; Lionel Bueno
Journal:  J Nutr       Date:  2007-08       Impact factor: 4.798

10.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

View more
  4 in total

1.  Evidence for Neuropeptide W Acting as a Physiological Corticotropin-releasing Inhibitory Factor in Male Chickens.

Authors:  Meng Liu; Guixian Bu; Yiping Wan; Jiannan Zhang; Chunheng Mo; Juan Li; Yajun Wang
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

Review 2.  Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk.

Authors:  Stavroula Baritaki; Eelco de Bree; Ekaterini Chatzaki; Charalabos Pothoulakis
Journal:  J Clin Med       Date:  2019-10-12       Impact factor: 4.241

Review 3.  Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.

Authors:  Enfu Tao; Zhenya Zhu; Chenmin Hu; Gao Long; Bo Chen; Rui Guo; Marong Fang; Mizu Jiang
Journal:  Front Cell Neurosci       Date:  2022-03-15       Impact factor: 5.505

Review 4.  Intestinal microbiome-gut-brain axis and irritable bowel syndrome.

Authors:  Gabriele Moser; Camille Fournier; Johannes Peter
Journal:  Wien Med Wochenschr       Date:  2017-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.